Prof. Juliane Walz receives SWISS BRIDGE Award 2024

🥳And the great news keeps coming in! Another recognition of our spokespersons Prof. Dr. Juliane Walz outstanding scientific work!
🏆She was recently awarded the SWISS BRIDGE Award 2024! She shares the award of 500,000 Swiss francs with Tobias Weiss from Universitätsspital Zürich 🇨🇭. The prize money of 250,000 Swiss francs each supports the implementation of two clinical studies investigating new, promising approaches to treating cancer with immunotherapies.

🔬The study by Juliane and her team focuses on research into a so-called bispecific antibody. This antibody, which was developed by 👨‍🔬 Professors Helmut Salih and Gundram Jung in Tübingen, is designed to specifically bind to two different proteins located on different cell types. One protein is located on the surface of immune cells, so-called T cells, and activates them. The other protein is found on tumor cells as well as in the surrounding tissue and blood vessels, which means that both structures can be specifically targeted by the antibody. 🤞 The researchers hope that this dual effect will be particularly effective in combating the tumor. 🎯The aim of the clinical trial is to test the safety and efficacy of the antibody in patients with metastatic cancer of the upper gastrointestinal tract, breast and sarcoma.

👏 Congratulations Juliane on this great recognition! 🍀 Wishing you and your team much success with conducting the clinical trial!